INMUNE BIO INC. Repayments of Debt
INMUNE BIO INC. (INMB) reported Repayments of Debt of $10.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2026-03-30
- INMUNE BIO INC. repayments of debt for the quarter ending 2024-12-31 was $2.50M, a 0.00% change year-over-year.
- INMUNE BIO INC. repayments of debt for the quarter ending 2024-09-30 was $2.50M.
- INMUNE BIO INC. repayments of debt for the quarter ending 2024-06-30 was $2.50M.
- INMUNE BIO INC. repayments of debt for the quarter ending 2024-03-31 was $2.50M, a 83.33% decline year-over-year.
- INMUNE BIO INC. repayments of debt for fiscal 2024 was $10.00M, a 100.00% increase from fiscal 2023.
- INMUNE BIO INC. repayments of debt for fiscal 2023 was $5.00M.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.00M derived: sum of 2 quarters · filed 2026-03-30 | $7.50M derived: sum of 3 quarters · filed 2026-03-30 | $10.00M 10-K · filed 2026-03-30 |
| 2024-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.00M derived: sum of 2 quarters · filed 2025-10-30 | $7.50M 10-Q · filed 2025-10-30 | $10.00M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.00M 10-Q · filed 2025-08-07 | $7.50M derived: sum of 3 quarters · filed 2025-08-07 | -$5.00M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.50M 10-Q · filed 2025-05-08 | $5.00M derived: sum of 2 quarters · filed 2025-05-08 | -$7.50M derived: sum of 3 quarters · filed 2025-05-08 | -$7.50M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$10.00M derived: sum of 2 quarters · filed 2025-03-27 | -$10.00M derived: sum of 3 quarters · filed 2025-03-27 | $5.00M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$12.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$12.50M derived: sum of 2 quarters · filed 2024-10-31 | $2.50M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $15.00M 10-Q · filed 2023-08-07 | ||
| 2023-03-31 | $15.00M 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |